NLSP

Companies
NASDAQ
NLS Pharmaceutics Ltd
Health Care
Price Chart
Overview

About NLSP

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Market Cap
$5.5M
Volume
74.6K
Avg. Volume
122.1K
P/E Ratio
-2.590909
Dividend Yield
0.00%
Employees
128.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.24
Low Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for NLSP.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, NLSP shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$5.5M
Volume74.6K
P/E Ratio-2.59
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2021
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how NLSP fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025